Literature DB >> 2167931

A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture.

T Paterson1, R D Everett.   

Abstract

Herpes simplex virus type 1 (HSV-1) encodes five immediate early (IE) genes of which at least three are involved in the transcriptional regulation of later classes of viral genes. Perhaps the most important of these regulatory proteins is Vmw175, a nuclear phosphoprotein of 1298 predicted amino acid residues. In the absence of functional Vmw175 the virus fails to activate early or late genes or to repress IE gene expression. All viruses of the sub-family alphaherpes-virinae encode polypeptides that are closely related to Vmw175. Mutational studies have shown that regions of homology within this family of gene regulators are generally of functional importance. One of the most striking conserved stretches of amino acid sequence is a run of serine residues followed by a highly acidic region in the amino-terminal fifth of the polypeptide. We have constructed an HSV-1 virus which lacks this serine-rich run within Vmw175. Surprisingly, the virus was viable in tissue culture cells and expressed apparently normal amounts of viral polypeptides. In plaque assays it was very slightly temperature-sensitive and, depending on the state of the host cells, could generate plaques with a syncytial morphology. The mutant protein was able to bind to DNA in a manner indistinguishable from that of the wild-type polypeptide. We conclude that despite its conservation in all of the alphaherpes-virinae so far sequenced, the serine-rich homology is not important for virus growth in tissue culture.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167931     DOI: 10.1099/0022-1317-71-8-1775

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  25 in total

1.  Mapping the sequences that mediate interaction of the equine herpesvirus 1 immediate-early protein and human TFIIB.

Authors:  H K Jang; R A Albrecht; K A Buczynski; S K Kim; W A Derbigny; D J O'Callaghan
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 2.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

3.  Gene transfer of NMDAR1 subunit sequences to the rat CNS using herpes simplex virus vectors interfered with habituation.

Authors:  V T Cheli; M F Adrover; C Blanco; E Rial Verde; V Guyot-Revol; R Vidal; E Martin; L Alché; G Sanchez; M Acerbo; A L Epstein; D Jerusalinsky
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

4.  An early gene maps within and is 3' coterminal with the immediate-early gene of equine herpesvirus 1.

Authors:  R N Harty; D J O'Callaghan
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon.

Authors:  H M Karpoff; M D'Angelica; S Blair; M D Brownlee; H Federoff; Y Fong
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

6.  An enhanced packaging system for helper-dependent herpes simplex virus vectors.

Authors:  T A Stavropoulos; C A Strathdee
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

7.  An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.

Authors:  A I Geller; K Keyomarsi; J Bryan; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons.

Authors:  S Song; Y Wang; S Y Bak; M J During; J Bryan; O Ashe; D B Ullrey; L E Trask; F D Grant; K L O'Malley; H Riedel; D S Goldstein; K A Neve; G J LaHoste; J F Marshall; J W Haycock; R L Neve; A I Geller
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

9.  Mutational analysis of varicella-zoster virus major immediate-early protein IE62.

Authors:  L Baudoux; P Defechereux; S Schoonbroodt; M P Merville; B Rentier; J Piette
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

10.  Isolation of a herpes simplex virus type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype.

Authors:  P A Johnson; M G Best; T Friedmann; D S Parris
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.